About Therismos
Therismos is a company based in Bromsgrove (United Kingdom) founded in 2011 was acquired by Cannaray in September 2019. Therismos operates in a competitive market with competitors including McKesson, Resilience, Entero Healthcare, BioAscent and Zhejiang Mingdu Zhikong Technology, among others.
- Headquarter Bromsgrove, United Kingdom
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website therismos.co.uk
- Acquired by Cannaray (Sep 2019)
Investors in Therismos
Therismos has secured backing from 1 investor. Prominent investors backing the company include Cannaray.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of cannabis-based wellness products to improve health | 2018 | cannaraycbd.com | London, United Kingdom |
Investor details for Therismos
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Therismos
2 dated milestones of Therismos across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Therismos is founded.
- Exit Acquired by Cannaray.
Competitors of Therismos
Therismos operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as McKesson, Resilience, Entero Healthcare, BioAscent and Zhejiang Mingdu Zhikong Technology, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| mckesson.com | 1833 | Irving, United States | – | 51,000 | Products and services are provided in the healthcare industry. | |
| resilience.com | 1995 | San Diego, United States | $1.99B | – | Supply chain services for biopharma sector are provided. | |
| enterohealthcare.com | 2018 | Mumbai, India | $59.67M | 817 | India's leading healthcare products distribution platform | |
| bioascent.com | 2013 | Motherwell, United Kingdom | $3.7M | 41 | Compound management solutions are offered for drug discovery processes. | |
| mingdutech.com | 2017 | Hangzhou, China | $73.06M | – | AI-based logistics services are provided in Hangzhou, China. | |
| aspisotopes.com | 2021 | Boca Raton, United States | – | 4 | Supply chain solution services for isotope production are provided. | |
| wipak.com | 2010 | Helsinki, Finland | – | – | Provider of packaging and logistic services | |
| viveo.com.br | 1996 | Sao Paulo, Brazil | – | – | Provider of logistic and supply chain services for biopharma sector | |
| parexcellence.com | 1997 | Cincinnati, United States | – | – | Supply chain logistics services are provided for the biopharma sector. |
Detailed competitors of Therismos
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Therismos
Complete news archive for Therismos
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Therismos
10 companies that operate in the same segment as Therismos (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Therismos
Therismos was founded in 2011.
Therismos is headquartered in Bromsgrove, United Kingdom. It is registered at Bromsgrove, Worcestershire, United Kingdom.
Therismos was founded in 2011 and is located in Bromsgrove, United Kingdom. Pharmaceutical supply chain management, product launch management, and handling of unlicensed products and Controlled Drugs are offered as core services. Supplies for Named Patient Programmes, Compassionate Use Programmes, and clinical trials are managed, including ambient stored products, cold chain products, and controlled substances. Operations focus on the pharmaceutical sector with an emphasis on regulatory compliance.
Therismos's top competitors include Entero Healthcare, McKesson and Resilience.
Therismos has 1 investor. Key investors include Cannaray.
Yes. Therismos was acquired by Cannaray in September 2019.